IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FRACANZANI, ANNA LUDOVICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 27.198
NA - Nord America 24.205
AS - Asia 21.405
Continente sconosciuto - Info sul continente non disponibili 2.929
SA - Sud America 1.861
AF - Africa 468
OC - Oceania 102
Totale 78.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.179
GB - Regno Unito 9.258
CN - Cina 6.419
IT - Italia 6.122
SG - Singapore 5.570
DE - Germania 2.896
BD - Bangladesh 2.211
SE - Svezia 1.997
RU - Federazione Russa 1.977
HK - Hong Kong 1.728
VN - Vietnam 1.552
BR - Brasile 1.344
FR - Francia 1.011
NL - Olanda 1.007
IN - India 925
TR - Turchia 766
KR - Corea 693
CA - Canada 654
UA - Ucraina 593
IE - Irlanda 585
FI - Finlandia 516
JP - Giappone 355
PL - Polonia 289
ID - Indonesia 270
EU - Europa 264
CO - Colombia 189
ES - Italia 160
DK - Danimarca 156
MX - Messico 148
CI - Costa d'Avorio 141
AR - Argentina 118
BE - Belgio 110
TW - Taiwan 108
IQ - Iraq 92
AU - Australia 91
CH - Svizzera 90
PH - Filippine 77
AT - Austria 74
GR - Grecia 74
EG - Egitto 71
IR - Iran 71
TH - Thailandia 65
ZA - Sudafrica 64
MY - Malesia 62
VE - Venezuela 54
PK - Pakistan 52
RO - Romania 52
UZ - Uzbekistan 50
CL - Cile 49
EC - Ecuador 48
SA - Arabia Saudita 41
CR - Costa Rica 38
JM - Giamaica 37
AE - Emirati Arabi Uniti 31
KE - Kenya 31
IL - Israele 30
DZ - Algeria 29
JO - Giordania 27
AZ - Azerbaigian 26
CZ - Repubblica Ceca 24
NO - Norvegia 24
NP - Nepal 24
TN - Tunisia 24
MA - Marocco 23
PR - Porto Rico 23
PT - Portogallo 23
RS - Serbia 21
HN - Honduras 20
MO - Macao, regione amministrativa speciale della Cina 20
TT - Trinidad e Tobago 19
PY - Paraguay 18
PE - Perù 17
LT - Lituania 16
LU - Lussemburgo 16
BO - Bolivia 15
KZ - Kazakistan 15
LK - Sri Lanka 15
HU - Ungheria 14
NI - Nicaragua 14
OM - Oman 14
GT - Guatemala 13
HR - Croazia 13
PA - Panama 13
AL - Albania 11
ET - Etiopia 11
NG - Nigeria 11
NZ - Nuova Zelanda 11
SI - Slovenia 11
KG - Kirghizistan 10
PS - Palestinian Territory 10
SC - Seychelles 10
SY - Repubblica araba siriana 10
AM - Armenia 9
EE - Estonia 9
SV - El Salvador 9
BG - Bulgaria 8
DO - Repubblica Dominicana 8
GE - Georgia 8
LB - Libano 8
LV - Lettonia 8
Totale 75.337
Salva come PNG Salva come JPEG
Città #
Southend 8.638
Singapore 3.221
Ashburn 2.475
Houston 1.587
Milan 1.569
Hong Kong 1.531
Dallas 1.391
San Jose 1.388
Chandler 1.374
Beijing 1.098
Council Bluffs 1.050
Seattle 811
Santa Clara 783
Princeton 662
Frankfurt am Main 650
Los Angeles 631
Wilmington 591
Dublin 571
New York 530
Fairfield 469
Jacksonville 448
Ho Chi Minh City 441
Dearborn 409
Hanover 394
Ann Arbor 389
Bengaluru 370
Boardman 367
Hanoi 346
Nanjing 345
Lauterbourg 340
Buffalo 338
Munich 332
Hefei 311
Toronto 309
Rome 302
Moscow 292
Guangzhou 280
Shanghai 279
Woodbridge 271
Redmond 266
Cambridge 247
Warsaw 241
Mountain View 231
Des Moines 227
Helsinki 207
The Dalles 196
Andover 195
Sakarya 188
Phoenix 175
Serra 175
Tokyo 174
Jakarta 161
São Paulo 149
Bogotá 144
Chicago 140
Abidjan 139
Somerville 136
Grafing 127
Istanbul 127
Jinan 121
Cangzhou 120
Naples 119
Columbus 116
Seoul 116
Shenyang 116
Sunnyvale 115
Hangzhou 110
Tianjin 109
Eitensheim 105
Turin 105
Changsha 102
Redwood City 99
Berlin 92
Nanchang 92
Fuzhou 91
Atlanta 90
Da Nang 88
Saint Petersburg 79
Montreal 76
Shenzhen 74
Haiphong 73
Hebei 73
Dong Ket 71
London 71
Amsterdam 70
Brooklyn 69
Brussels 69
Palermo 66
Pisa 66
Nuremberg 63
Bologna 60
Wuhan 59
Boston 58
Denver 54
Florence 54
Orem 53
Bitonto 52
Genoa 52
San Francisco 52
Chengdu 49
Totale 44.597
Salva come PNG Salva come JPEG
Nome #
Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic Fatty liver disease 1.657
A second update on mapping the human genetic architecture of COVID-19 1.573
Mapping the human genetic architecture of COVID-19 1.267
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 904
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 648
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 565
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis 557
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 484
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation 471
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 453
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma 442
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 437
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 399
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 394
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 392
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 370
Use of high flow nasal cannula in patients with acute respiratory failure in general wards under intensivists supervision: a single center observational study 365
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma 352
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression : An Observational Study in Patients with Nonalcoholic Fatty Liver Disease 350
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 344
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 335
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 334
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease 333
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 333
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease 332
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 331
MAFLD in COVID-19 patients: an insidious enemy 331
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 329
β-Klotho gene variation is associated with liver damage in children with NAFLD 329
Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF- DRY-OFF study 328
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 323
High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload 322
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 321
The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload 313
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 313
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls 312
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 303
PNPLA3 I148M polymorphism, etiology, and clinical features of hepatocellular carcinoma 301
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 301
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 300
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations 296
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease 296
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease 294
Carotid artery intima-media thickness in nonalcoholic fatty liver disease 291
Liver fat accumulation is associated with circulating PCSK9 levels 285
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 283
Vascular damage in patients with nonalcoholic fatty liver disease : Possible role of iron and ferritin 283
Acquired hepatocerebral degeneration (AHD) : a peculiar neurological impairment in advanced chronic liver disease 282
Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease 279
Risk of NASH and severe fibrosis in patients with NAFLD and low visceral adiposity 276
Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study 276
Homozygosity for the PNPLA3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 273
α1-Antitrypsin mutations in NAFLD : high prevalence and association with altered iron metabolism but not with liver damage 272
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 270
Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up 269
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation : preliminary results 269
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease 268
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD 268
Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease : a case control study 265
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 264
Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis 262
Variables significantly associated with non alcoholic steatohepatitis (NASH) and fibrosis in patients with non alcoholic fatty liver disease (NAFLD) 260
Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling—a propensity score-adjusted observational study 260
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 260
Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity 257
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 257
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma 257
Echocardiographic epicardial fat thickness in non alcoholic fatty liver disease: a possible marker of metabolic syndrome and early vascular damage 256
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease 254
Increased circulating adiponectin in males with chronic HCV hepatitis 254
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes : evidence in NAFLD patients and cell cultures 253
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 252
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 250
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 248
Liver fat accumulation is associated with circulating PCSK9 248
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis 247
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with non-alcoholic fatty live 246
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 245
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients 243
Risk of early atherosclerosis by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease and low visceral adiposity 242
Nutrients, genetic factors, and their interaction in non-alcoholic fatty liver disease and cardiovascular disease 242
Risk of early atherosclerosis by carotid artery intima- media thickness in patients with non alcoholic fatty liver disease and low visceral adiposity 241
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study 241
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 241
Progression of carotic atherosclerotic damage is related to alt values in patients with non alcoholic fatty liver disease 240
The risk of severe liver disease in NAFLD with normal amino-transferase levels : a role for insulin and diabetes 239
Impact of natural neuromedin-B receptor variants on iron metabolism 239
Insulin related early andothelial dysfuction in patients with non alcoholic fatty liver disease (NAFLD) 238
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 238
Aberrant methylation of oncosuppressor genes detected in the peripheral blood of patients with chronic hepatitis C and hepatocellular carcinoma 237
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 236
Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD 235
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis 235
HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients 234
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients : a nationwide, prospective, 3-year follow-up study in Italy 233
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia 233
Hypermethylation of oncosuppressor genes in hereditary hemochromatosis 232
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 230
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 227
Association between heterozygosity for HFE gene mutations and hepatis viruses in hepatocellular carcinoma 226
Totale 34.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 196.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.612 0 198 267 471 351 360 421 353 595 402 421 773
2022/20235.068 626 533 457 467 602 947 128 362 495 75 252 124
2023/20243.800 142 324 208 252 930 255 231 183 126 259 415 475
2024/202510.585 412 1.022 333 1.013 680 456 527 1.044 699 1.028 1.133 2.238
2025/202624.890 2.122 1.738 2.573 1.754 2.013 1.387 2.705 1.459 2.372 1.745 2.727 2.295
2026/20273.324 1.632 1.692 0 0 0 0 0 0 0 0 0 0
Totale 78.168